In a mouse model of breast cancer, the administration of CAR-M cells expressing an anti-HER2 antibody and the transmembrane and intracellular domain of CD147 allows to specifically target cancer cells expressing HER2. This evidence concerns the gene ERBB2 and breast carcinoma.